Sedating and activating side effects of first ‐time SGA use persist

The side effects of sedation and activation caused by first‐time use of antipsychotics in young people are possibly more linked to parameters such as age rather than the specific medication, according to new research. For the study, the researchers used the Second‐Generation Antipsychotic Treatment Indication, Effectiveness and Tolerability in Youth (SATIETY) study to assess activating and tranquilizing effects of second‐generation antipsychotics (SGAs) in youth. Four SGAs were studied: quetiapine, olanzapine, risperidone, and aripiprazole.
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: Schizophrenia Source Type: research